Background and Purpose: The timing of aneurysm surgery after subarachnoid hemorrhage is a major neurosurgical controversy addressed by the International Cooperative Study on the Timing of Aneurysm Surgery (1980)(1981)(1982)(1983). The present report examines the results of this trial in the subgroup of patients admitted to North American centers.
I n the early 1980s, the optimal timing of surgery for ruptured cerebral aneurysms was the subject of considerable controversy. 1 The majority opinion in North America at that time was that the best results were obtained when the operation could be delayed until the clinical condition of the patient was stable and the reactive brain swelling accompanying the initial hemorrhage had subsided. 23 On the other hand, others argued that delaying surgery resulted in too much attrition from rebleeding from the aneurysm and that early surgery for clipping of the aneurysm could be performed with acceptable results. 45 In an effort to address this issue, a large, design analogous to the "intent to treat" paradigm was used, whereby neurosurgeons were required to specify the planned time for aneurysm surgery prospectively at the time of patient admission. This approach avoids the selection bias inherent in analysis of only those patients undergoing operation, who customarily are chosen because of their relatively good preoperative conditions, and accounts for those patients who never undergo operation because they die or are neurologically ruined by rebleeding or vasospasm prior to their planned surgery. The results in those patients actually undergoing surgery are also reported here only to provide a comparison with other purely surgical series.
Briefly, eligible patients were admitted to a participating center on days 0-3 after their first major subarachnoid hemorrhage (SAH) from a saccular aneurysm (day 0 is the calendar day of the hemorrhage). Exclusion criteria included SAH from a fusiform, mycotic, or traumatic aneurysm or from unknown cause, need for emergency evacuation of an intracranial hematoma, and severe complicating medical illnesses on admission.
After completion of the initial examination, surgeons were required to specify at which time interval they planned to conduct surgery for treatment of the aneurysm. Intervals that could be chosen were days 0-3, days 4-6, days 7-10, days 11-14, days 15-32, and no surgery planned. The actual surgery, when and if performed, was conducted as required by the patient's clinical condition and neurological status. However, for the overall management results, all subsequent medical, neurological, and surgical complications were attributed to the planned surgery interval.
Outcome at 6 months after the initial hemorrhage was assessed using the Glasgow Outcome Scale 8 by an evaluator who was blinded to the patient's hospital course and planned surgery interval. The participating surgeon also designated the primary cause of death or disability. Audit of a 24% sample of the Glasgow Outcome Scale scores confirmed excellent agreement with the evaluator assessments.
Standardized forms were used to collect data on demographic information, initial neurological condition, results of angiography and head computed tomography (CT) scanning, preoperative and postoperative medications and other interventions (e.g., cerebrospinal fluid drainage), neurological complications including rebleeding and vasospasm, and complications of medical and surgical therapy. Focal ischemic deficits from all causes were tabulated.
Comparison of groups with categorical variables was done with contingency table methods and significance determined by a x 2 test. 9 Continuous variables were compared using a t test, and significance was determined by the t distribution. Adjusted results of mortality and good recovery were calculated using proportional hazards regression with prognostic variables and center variables as covariates. The prognostic variables used were derived from an analysis of the outcomes from the first half of the overall study 6 and included admission neurological condition, age, preexisting med- ical conditions, systolic blood pressure on admission, thickness of SAH clot on admission CT scan, presence of intracerebral or intraventricular clot on admission CT scan, aneurysm site, and presence of angiographic vasospasm on admission angiogram. Center effects were determined from regression of prognostic and treatment variables and comparison of observed and expected results. Significance of adjusted results was determined using the log likelihood statistic with comparison to a x 2 distribution. 10
Results
Of the 3,521 patients admitted to the entire study, 772 (21.9%) were admitted from the North American centers. The patients in North America were compared with those elsewhere. The mean±SD age of the patients in North America was 49.2±14.3 years. The degree of female preponderance was greater in North American centers (68.3%) than in other geographical regions (59.1%, /?<0.001). A greater percentage of patients in North America were admitted on the same calendar day as the hemorrhage (57.6% versus 46.4%,p<0.001).
Preexisting medical conditions were reported with approximately the same frequency in North America as in other geographic regions. Hypertension was the most commonly reported preexisting illness (24%).
Only 46% of the patients were fully alert on admission, but nearly three fourths had no motor or versus 14.2%) were seen more frequently on admission CT scans in North America (p<0.001).
The size, distribution, and number of aneurysms demonstrated on the initial angiograms of the North American patients were similar to those reported in other large series. 11 Seventy-nine percent had a single aneurysm, and most (73.7%) were <12 mm in diameter. One third (33.9%) were located on the internal carotid artery, whereas 35.3% arose from the anterior cerebral/anterior communicating artery complex. Although the absolute frequencies were relatively low, North American patients were more likely to have giant aneurysms (3.2%) and basilar artery aneurysms (6.0%) than patients in other regions. Table 2 lists the preoperative and postoperative medications administered. The most commonly used medications were steroids, anticonvulsants, sedatives, and antifibrinolytic agents. All of these drugs were administered more frequently in North America than in any other geographical region. The average number of medications administered preoperatively per patient in North America was 2.8. Hypervolemia (volume expansion) was used either preoperatively or postoperatively in 44.8% of pa- •Adjusted refers to mortality controlled for differences in prognostic variables between groups (see "Subjects and Methods").
tFollow-up in some cases >6 months. 
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Adjusted refers to data controlled for differences in prognostic variables between the groups (see "Subjects and Methods").
tients. Hypervolemia combined with induced hypertension was used in 10%.
Preoperative and postoperative management routines were consistent with practices in other geographic regions, except that intracranial pressure monitoring was more likely to be used in North American centers (11.9% versus 2.8%,p<0.001). Ventricular cerebrospinal fluid drainage, a practice commonly used postoperatively in Japan (32% of patients), was not used as frequently in North America (6%). Total   145  4  82  61  11  12  77  22  61  66  22  12  30  7  12  19  12  7  9  4  8  8  8  33  Table 3 gives the planned versus actual surgery intervals for the North American subgroup. One third (33.9%) of patients had early surgery planned for within the first 3 days from hemorrhage, whereas 48% had surgery planned for after the first week. Compared with other regions (particularly Japan, where 75% of patients had surgery planned for days 0-3), North American surgeons were more likely to plan for surgery after the first week. Those patients who were planned for surgery on days 0-3 were more likely to undergo actual surgery in that interval than those planned for later intervals. Those patients who had surgery planned for after day 7 frequently had surgery delayed or not performed because of neurological deterioration or death. Overall, 63.1% actually had surgery during the planned interval.
Preoperative and postoperative neurological and medical complications were reported more frequently in North American patients (Tables 4 and 5 ). Focal ischemic deficits (predominantly from symptomatic vasospasm), brain swelling, and hydrocephalus were reported in 34.8%, 13.6%, and 18.5% of North American patients, respectively. Several medical complications, including pulmonary disorders and blood pressure abnormalities, were reported more frequently in North American centers. This observation may reflect more intensive monitoring and reporting in these patients or may be a complication of the more aggressive medical interventions outlined previously.
Despite the increase in neurological and medical complications reported, the mortality rate of patients treated in North American centers was better than that in other regions ( Table 6 ). The mortality rate at 6 months, adjusted for baseline prognostic variables, was significantly lower in North American centers (p=0.0003). Comparison of unadjusted Glasgow Outcome Scale scores shows similar proportions of patients attaining good recovery at follow-up. Caution should be used in interpreting the unadjusted data, however. Table 7 presents the primary causes of death or disability listed by planned surgical interval. Of the 64 patients initially deemed to be unfit for surgery, 69% died, most as a direct consequence of the initial hemorrhage. In the patients planned for surgery on days 15-32, morbidity and mortality from direct effects was 18.9%. In the other planned surgical intervals, morbidity and mortality from direct effects averaged 9-10%. Although mortality from surgical complications was higher in the groups of patients planned for surgery before day 10, morbidity from surgical complications was higher in patients planned for days . As with the overall study, death and disability from vasospasm was higher in the group planned for surgery on days 0-6, whereas those planned for late intervals (after day 14) were more likely to succumb to rebleeding.
In terms of overall outcome ( ity in patients planned for surgery during days 0-3 was 15% and was equivalent to that of the later planned surgical intervals. The percentage of patients achieving good recovery at 6 months, however, was significantly better in those patients planned for surgery in days 0-3. Of those patients actually undergoing surgery, the results were best in the days 11-14 interval, consistent with reports from other surgical series 1213 and reflecting the attrition and selection bias that occurs during days 0-10.
With regard to subgroups that might benefit from a particular surgical timing strategy, Table 9 shows outcomes by planned surgical interval and admission level of consciousness. Alert patients generally did well regardless of the planned surgical interval, but drowsy patients had better outcomes if surgery was planned before day 6 or after day 14. Comatose patients with surgery planned for after the first week generally had better outcomes, although the mortality was high in all planned surgical intervals for this group of patients.
Discussion
This study describes several key aspects of the admission characteristics, elements of neurosurgical practice, and results of treatment in a large cohort of patients with ruptured aneurysms admitted to several major neurosurgical referral centers in North America from 1980 through 1983. As such, it represents a historical blueprint of the results of SAH treatment before the widespread use of interventions for cerebral vasospasm, such as intentional hypervolemia and induced hypertension 14 or calcium antagonist drugs. 15 Without an effective treatment for vasospasm, patients were more likely to die of or to be disabled by this disorder than by any other cause, except for direct effects of the initial hemorrhage ( Figure 1) . Rebleeding also remained a major prob-lem, perhaps related to the prevailing philosophy favoring delayed surgery at the time.
In contrast to the results of the overall study, overall good recovery, adjusted for prognostic factors and center variability, was better in the group planned for surgery during days 0-3 than that planned for surgery during days 11-32 (p<0.01, x 2 test). Results were worst when surgery was planned for the days 7-10 period, which is now recognized as the period of greatest risk for angiographic and symptomatic cerebral vasospasm. While mortality from surgical complications was slightly reduced in those assigned the delayed strategy, surgical morbidity was not. With potentially effective strategies for managing vasospasm now available, 16 there is evidence that more North American neurosurgeons are adopting a preference for early surgery. 17 As a subset of a much larger, international epidemiological survey, the results of treatment in North American neurosurgical centers compared quite favorably with results reported from other regions. 1819 As reported previously, the North American and Japanese 6-month mortality and good recovery rates were virtually identical (22% and 58%, respectively) and were superior to results reported from other regions. 6 The results of this trial provide impetus for further research into treatment for SAH patients. It was discouraging to discover that although 75% of patients with recently ruptured aneurysms were admitted in an alert or drowsy state with no motor or speech deficits, only 58% were living independently without a major neurological deficit 6 months later. Advances in the management of rebleeding and vasospasm, complications that occur frequently while patients are already hospitalized, should translate into immediately tangible improvements in overall outcome. As both these phenomena occur soon after the initial hemorrhage, it behooves primary care and emergency physicians to become more adept at early diagnosis and rapid referral of SAH patients if the devastating consequences of rebleeding and vasospasm are to be prevented.
